Article Details
Retrieved on: 2022-06-04 20:56:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The use of avelumab (Bavencio) as first-line maintenance treatment was associated with long-term overall survival (OS) benefit in patients with ...
Article found on: www.urologytimes.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here